Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

APRI as a predictor of early viral response in chronic hepatitis C patients.

World journal of gastroenterology - 21 Oct 2009

Mata-Marín José A, Fuentes-Allen José L, Gaytán-Martínez Jesús, Manjarrez-Téllez Bulmaro, Chaparro-Sánchez Alberto, Arroyo-Anduiza Carla I

Abstract excerpt

AIM: To evaluate the aspartate aminotransferase (AST) to platelet ratio index (APRI) as a predictive factor of early viral response in chronic hepatitis C naive patients. METHODS: We performed an ambispective case-control study. We enrolled chronic hepatitis C naive patients who were evaluated to start therapy with PEGylated interferon alpha-2b (1.5 mug/kg per week) and ribavirin (> 75 kg: 1200 mg and < 75 kg:...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aspartate Aminotransferases
Share to Hepatitis C, Chronic

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Interferon-alpha

Share to Interferon alpha-2

Share to Logistic Models

Share to Platelet Count

Share to Polyethylene Glycols

Share to Viral Load

Source

Open in PubMed Open full text

Identifiers

PMID: 19842223
DOI: 10.3748/wjg.15.4923
PMCID: PMC2764970

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

APRI as a predictor of early viral response in chronic hepatitis C patients.PMID 19842223Read ↗

[Treatment of chronic hepatitis C virus infection. A study of best predictors for response].Semantic proximity Read ↗

Rapid virologic response in chronic hepatitis C genotype 1: Evaluation of pretreatment factors in patients.Semantic proximity Read ↗

Predictive value of rapid virological response and early virological response on sustained virological response in HCV patients treated with pegylated interferon alpha-2a and ribavirin.Semantic proximity Read ↗

[Is APRI score a suitable tool for prediction of fibrosis in Tunisian patients with genotype 1 chronic viral hepatitis C?].Semantic proximity Read ↗

Early identification of achieving a sustained virological response in chronic hepatitis C patients without a rapid virological response.Semantic proximity Read ↗

Sustained virological responses following standard anti-viral therapy in decompensated HCV-infected cirrhotic patients.Semantic proximity Read ↗

Predictive value of complete and partial early virological response on sustained virological response rates of genotype-4 chronic hepatitis C patients treated with PEG-interferon plus ribavirin.Semantic proximity Read ↗

Is the rapid virologic response a positive predictive factor of sustained virologic response in all pretreatment status genotype 1 hepatitis c patients treated with peginterferon-alpha2b and ribavirin?Semantic proximity Read ↗

Plasma/erythrocyte ribavirin x100 ratio as an indicator of sustained virological response in HCV genotype 1 patients with early virological response.Semantic proximity Read ↗

[Prediction of sustained viral response to combinational therapy with interferon and ribavirin in chronic hepatitis C by rapid viral response].Semantic proximity Read ↗

Rapid virological response as a predictor of sustained response in HCV-infected patients with persistently normal alanine aminotransferase levels: A multicenter study.Semantic proximity Read ↗

Hepatitis C virus Core Antigen as a predictor of non-response in genotype 1 chronic hepatitis C patients treated with peginterferon alpha-2b plus ribavirin.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.